<SEC-DOCUMENT>0001610618-25-000020-index.html : 20250306
<SEC-HEADER>0001610618-25-000020.hdr.sgml : 20250306
<ACCEPTANCE-DATETIME>20250306165249
ACCESSION NUMBER:		0001610618-25-000020
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		5
REFERENCES 429:			333-203434
REFERENCES 429:			333-210263
REFERENCES 429:			333-216722
REFERENCES 429:			333-228282
REFERENCES 429:			333-231326
REFERENCES 429:			333-236874
REFERENCES 429:			333-253545
REFERENCES 429:			333-259219
REFERENCES 429:			333-263350
REFERENCES 429:			333-270781
REFERENCES 429:			333-278872
REFERENCES 429:			333-281523
FILED AS OF DATE:		20250306
DATE AS OF CHANGE:		20250306
EFFECTIVENESS DATE:		20250306

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cidara Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001610618
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				461537286
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-285607
		FILM NUMBER:		25716041

	BUSINESS ADDRESS:	
		STREET 1:		6310 NANCY RIDGE DRIVE
		STREET 2:		SUITE 101
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-752-6170

	MAIL ADDRESS:	
		STREET 1:		6310 NANCY RIDGE DRIVE
		STREET 2:		SUITE 101
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	K2 THERAPEUTICS, INC.
		DATE OF NAME CHANGE:	20140611
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>cdtxs-82025x03x06.htm
<DESCRIPTION>CIDARA THERAPEUTICS, INC. FORM S-8
<TEXT>
Document 1 - file: cdtxs-82025x03x06.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-FILING FEES <SEQUENCE>2 <FILENAME>exhibit1072025-03x06.htm <DESCRIPTION>CALCULATION OF FILING FEE TABLES <TEXT> Document 2 - file: exhibit1072025-03x06.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>3 <FILENAME>exhibit512025-03x06.htm <DESCRIPTION>CONSENT OF COOLEY LLP <TEXT> Document 3 - file: exhibit512025-03x06.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>4 <FILENAME>exhibit2312025-03x06.htm <DESCRIPTION>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM <TEXT> Document 4 - file: exhibit2312025-03x06.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>cooleylogo.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: cooleylogo.jpg
</DOCUMENT> </SEC-DOCUMENT>